MARKET

PCVX

PCVX

Vaxcyte, Inc.
NASDAQ
47.17
-1.61
-3.30%
After Hours: 47.31 +0.14 +0.30% 19:28 05/20 EDT
OPEN
49.11
PREV CLOSE
48.78
HIGH
50.09
LOW
46.39
VOLUME
4.14M
TURNOVER
--
52 WEEK HIGH
65.00
52 WEEK LOW
29.08
MARKET CAP
6.81B
P/E (TTM)
-6.8439
1D
5D
1M
3M
1Y
5Y
1D
Why Vaxcyte (PCVX) Is Down 9.7% After Steeper Q1 Losses And Accelerated R&D Spending
Simply Wall St · 13h ago
Weekly Report: what happened at PCVX last week (0511-0515)?
Weekly Report · 2d ago
Notable Tuesday Option Activity: UNH, MDB, PCVX
NASDAQ · 05/12 19:28
Weekly Report: what happened at PCVX last week (0504-0508)?
Weekly Report · 05/11 09:20
Assessing Vaxcyte (PCVX) Valuation After Key VAX 31 Trial Milestones And Balance Sheet Update
Simply Wall St · 05/11 03:19
Vaxcyte (PCVX) Is Down 10.1% After Wider Q1 Loss But Completing Key VAX-31 Phase 3 Enrollment
Simply Wall St · 05/08 20:37
Guggenheim Remains a Buy on Vaxcyte (PCVX)
TipRanks · 05/08 11:54
Vaxcyte Down Over 10%, On Track for Largest Percent Decrease Since May 2025 -- Data Talk
Dow Jones · 05/07 19:03
More
About PCVX
Vaxcyte, Inc. is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. The Company's pipeline includes VAX-31, VAX-24 and VAX-XL. VAX-31, a 31-valent PCV candidate being evaluated in the OPUS Phase III adult clinical program and in a Phase II infant clinical program, is being developed for the prevention of IPD and is the broadest-spectrum PCV candidate in the clinic today. VAX-24, a 24-valent PCV candidate, is designed to cover more serotypes than any infant PCV on-market. VAX-XL leverages the Company’s carrier-sparing, site-specific conjugation technology. It is re-engineering the way highly complex vaccines are made through XpressCF, its cell-free protein synthesis platform exclusively licensed from Sutro Biopharma, Inc. Its pipeline also includes VAX-A1, a prophylactic vaccine candidate designed to prevent Group A Strep infections, and VAX-GI, a vaccine candidate designed to prevent Shigella.

Webull offers Vaxcyte Inc stock information, including NASDAQ: PCVX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PCVX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PCVX stock methods without spending real money on the virtual paper trading platform.